Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis
Open Access
- 23 October 2018
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 126 (11) , 950-958
Abstract
Background: New cervical cancers continue to be diagnosed despite the success of Papanicolaou (Pap) tests. In an effort to identify pitfalls that limit the diagnosis of adenocarcinoma, the authors reviewed the cytologic characteristics of endocervical adenocarcinomas in their patient population.Methods: Liquid‐based cytology slides from 45 women who had concurrent, histologically confirmed cervical adenocarcinomas were reviewed retrospectively and semiquantitatively for 25 key cytologic traits. The original sign‐out diagnosis, available clinical findings, and high‐risk human papillomavirus (HR HPV) results also were noted.Results: Abundant tumor cellularity, nuclear size from 3 to 6 times normal, abundant 3‐dimensional tumor cell groups, round cell shape, and cytoplasmic neutrophils characterized the 23 cases that were identified correctly as adenocarcinomas. Key reasons for undercalls included low tumor cellularity and low‐grade columnar morphology; these also tended to correlate with low‐grade or unusual adenocarcinoma variants on histology. Overall, 73% of adenocarcinomas had a concurrent positive HR HPV test.Conclusions: Most endocervical adenocarcinomas can be diagnosed accurately in cases with classical features, but some cases continue to be problematic when evaluated based on cytologic features alone. Reflex HPV testing may help increase Pap test sensitivity for challenging cases that have atypical glandular cells of undetermined significance. Occasional cases with negative HR HPV test results remain of concern.Keywords
Funding Information
- National Cancer Institute (Contract N02-CP-31102, Walker (PI))
This publication has 33 references indexed in Scilit:
- Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practiceGynecologic Oncology, 2011
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinantsInternational Journal of Cancer, 2009
- Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and DeterminantsCancer Epidemiology, Biomarkers & Prevention, 2009
- Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in OklahomaInternational Journal of Cancer, 2008
- Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervixAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2007
- Adenocarcinoma in situ of the uterine cervixCancer, 2004
- Glandular Lesions of the Cervix on Thin-Layer Pap TestsActa Cytologica, 2004
- Atypical Glandular Cells of Undetermined Significance (AGUS)American Journal of Clinical Pathology, 2002
- Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervixCancer, 2001